The pooled DR was 89% for PSA≥0.5 ng/ml and 49% for PSA < 0.5ng/ml.<h4>Conclusion</h4>18F-DCFPyL PSMA PET/CT had good sensitivity and specificity for the diagnosis of prostate cancer. This evidence concerns the gene FOLH1 and Familial prostate cancer.